06 Nov 2017 BriaCell Provides Clinical Update on its Lead Vaccine Candidate, BriaVax™
06 Nov 2017 SOTIO Completes Enrolment of Phase III VIABLE Study in Late Stage Prostate Cancer
02 Nov 2017 United Neuroscience Presents Data for Phase 2 Active Vaccine Program UB-311 at the Clinical Trials on Alzheimer's Disease 2017 Meeting
02 Nov 2017 Inovio Pharmaceuticals Initiates Immuno-Oncology Clinical Study for Glioblastoma in Combination with Regeneron’s PD-1 Inhibitor
30 Oct 2017 Vaxart Announces Positive Safety and Immunogenicity Results for Its Oral Norovirus Vaccine in a Phase 1b Clinical Study
30 Oct 2017 FDA Approves the Roll-Over Combination Study with Checkpoint Inhibitor Immunotherapies to Allow Continued Access to BriaVax™ in Patients with Advanced Breast Cancer
27 Oct 2017 CureVac Initiates Phase I Clinical Trial of RNAdjuvant® Candidate as Intratumoral Therapy for Solid Tumors
26 Oct 2017 Vaxart Announces Positive Topline Results for its Oral Tablet Vaccine in Phase 2 Influenza Challenge Study
25 Oct 2017 Alopexx completes first-in-man trial of its novel, broad-spectrum anti-microbial vaccine
24 Oct 2017 Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study
23 Oct 2017 Shingrix approved in the US for prevention of shingles in adults aged 50 and over
21 Oct 2017 DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age
18 Oct 2017 Transgene Presents First Clinical Data Indicating that TG1050 Induces a Robust and HBV-Specific Cell-Mediated Immune Response in Patients with Chronic Hepatitis B
17 Oct 2017 Aimmune Therapeutics Announces Clinical Collaboration to Study AR101 with Regeneron and Sanofi’s Dupilumab for Peanut Allergy
17 Oct 2017 Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Immunotherapy with a PD-L1 Checkpoint Inhibitor in Advanced Bladder Cancer
12 Oct 2017 Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer
03 Oct 2017 PnuVax Awarded $29.4 Million USD Grant to Advance Innovative Vaccine into Clinical Trials
28 Sep 2017 Moderna Announces Publication in Molecular Therapy Characterizing Potent Immune Response Generated by Its mRNA Prophylactic Vaccines
27 Sep 2017 Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine
27 Sep 2017 Aduro Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Personalized Immunotherapy pLADD Based on Proprietary Neoantigen Technology
25 Sep 2017 Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against Chickenpox
21 Sep 2017 Bavarian Nordic Provides Update on its Universal RSV Vaccine
21 Sep 2017 Altimmune Announces its Phase 2 Flu Vaccine Trial with NasoVAX Open for Enrollment
19 Sep 2017 Novavax Initiates Phase 1/2 Trial of NanoFlu™ Vaccine in Older Adults
19 Sep 2017 Transgene: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up